Conditions: Major Depressive Disorder Idiopathic Parkinson Disease
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 151
Healthy volunteers: no

Brief summary:
This study aims to assess the tolerability of duloxetine, 60mg once daily, in open label fashion, in depressed patients with Parkinson's disease during 12 weeks treatment.

Detailed description:

Arms:
arm 1: Participants received duloxetine 30 milligram (mg) orally once daily (QD) for 1 week, followed by duloxetine 60 mg orally QD for 11 weeks

Interventions: intervention 1: Duloxetine hydrochloride
Intervention descriptions: intervention 1: Duloxetine 30 milligram (mg) once daily (QD) orally (PO) for 1 week, then duloxetine 60 mg QD PO for 11 weeks

Protocol document: